Sign In
En français • Register Now • Forgot Password •

Back to Program > Additional Important Practical Aspects

Contributors
Chair: Dr. Jeffrey Weitz
Hamilton, ON
 

Committee Members:

Dr. Alan Bell
Toronto,ON  
Dr. Denis Drouin
Quebec, QC  
Dr. Victor Huckell
Vancouver, BC  
Dr. Akbar Panju
Hamilton, ON  
Dr. Denis Roy
Montreal, QC  
Dr. James Tam
Winnipeg, MB  
Dr. Andrew Demchuk
Calgary, AB  
Dr. John Eikelboom
Hamilton, ON  
Dr. Jeannine Kassis
Montreal, QC  
Dr. Vinod Patel
St John's, NFLD  
Dr. Kevin Saunders
Winnipeg, MB  
Dr. Phil Teal
Vancouver, BC  
Dr. Paul Dorian
Toronto, ON  
Dr. Martin Green
Ottawa,ON  
Dr. Peter Lin
Toronto, ON  
Dr. Andre Roussin
Montreal, QC  
Dr. Mike Sharma
Ottawa, ON  
Dr. Richard Ward
Calgary, AB  
 

Review guideline recommendations for: Antithrombotic use in atrial fibrillation

Learning Objectives
  • Discuss additional important practical aspects in managing patients with atrial fibrillation at risk for stroke
  • Review guideline recommendations for: Antithrombotic use in atrial fibrillation
  • Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion
  • Perioperative management of patients receiving vitamin K antagonists and bridging anticoagulation
  • Management of atrial fibrillation patients with special considerations – myocardial infarction, hyperthyroidism, pregnancy, hypertrophic cardiomyopathy
  • Management of patients with different classifications of atrial fibrillation: newly discovered, recurrent paroxysmal, recurrent persistent or permanent
  • Discuss the importance of comorbidities, especially hypertension, in patients with atrial fibrillation
  • Describe a potential management strategy for switching patients from warfarin to dabigatran